The Joint Corp. (NASDAQ:JYNT) Receives $22.00 Average Price Target from Analysts

The Joint Corp. (NASDAQ:JYNT) has been assigned a consensus rating of “Moderate Buy” from the four ratings firms that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $22.00.

JYNT has been the topic of a number of recent analyst reports. Roth Mkm reiterated a “buy” rating and set a $16.00 target price (up from $13.00) on shares of Joint in a research note on Friday, May 3rd. StockNews.com raised Joint from a “hold” rating to a “buy” rating in a report on Monday, May 6th. Finally, B. Riley lifted their target price on Joint from $12.00 to $20.00 and gave the company a “buy” rating in a report on Monday, May 6th.

Joint Stock Down 4.1 %

Shares of JYNT stock opened at $13.68 on Friday. The firm has a 50 day moving average of $14.59 and a 200-day moving average of $12.61. Joint has a 52 week low of $7.31 and a 52 week high of $17.82. The company has a market cap of $204.79 million, a price-to-earnings ratio of -18.24 and a beta of 1.60.

Joint (NASDAQ:JYNT) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.03) by $0.09. Joint had a negative net margin of 9.24% and a positive return on equity of 3.94%. The business had revenue of $29.72 million during the quarter, compared to the consensus estimate of $29.17 million. Analysts anticipate that Joint will post 0.2 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Price T Rowe Associates Inc. MD grew its holdings in shares of Joint by 5.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company’s stock worth $229,000 after purchasing an additional 837 shares in the last quarter. Avondale Wealth Management grew its holdings in shares of Joint by 192.3% during the first quarter. Avondale Wealth Management now owns 19,000 shares of the company’s stock worth $248,000 after purchasing an additional 12,500 shares in the last quarter. Bridge City Capital LLC boosted its stake in Joint by 75.2% in the first quarter. Bridge City Capital LLC now owns 22,115 shares of the company’s stock worth $289,000 after buying an additional 9,492 shares in the last quarter. Corsair Capital Management L.P. purchased a new stake in Joint in the fourth quarter worth approximately $248,000. Finally, Boston Partners purchased a new stake in Joint in the fourth quarter worth approximately $279,000. Hedge funds and other institutional investors own 76.88% of the company’s stock.

Joint Company Profile

The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.